Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_assertion type Assertion NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_head.
- NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_assertion description "[Complete loss of EphB2 expression was observed in 177 (52.5%) of the 337 primary tumor and 41 (82%) of the 50 nodal metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_provenance.
- NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_assertion evidence source_evidence_literature NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_provenance.
- NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_assertion SIO_000772 20238226 NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_provenance.
- NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_assertion wasDerivedFrom befree-20150227 NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_provenance.
- NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_assertion wasGeneratedBy ECO_0000203 NP377025.RA8F8FNSAFyoJjNwYy4m0NCJU5bYshXp-5G4hEDQJBvNM130_provenance.